MedPath

Oncoscience AG

🇨🇭Switzerland
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.oncoscienceag.com

Clinical Trials

8

Active:4
Completed:4

Trial Phases

2 Phases

Phase 2:1
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (50.0%)
Phase 3
1 (50.0%)

Nimotuzumab in Adults With Glioblastoma Multiforma

Phase 3
Completed
Conditions
Adults With Glioblastoma Multiforma
Interventions
First Posted Date
2008-09-16
Last Posted Date
2012-12-03
Lead Sponsor
Oncoscience AG
Target Recruit Count
150
Registration Number
NCT00753246
Locations
🇩🇪

Dep. Neurosurgery, Univ. Hamburg, Hamburg, Germany

Nimotuzumab in Children With Intrinsic Pontine Glioma

Completed
Conditions
Diffuse Instrinsic Ponitine Glioma
First Posted Date
2007-11-21
Last Posted Date
2013-03-29
Lead Sponsor
Oncoscience AG
Target Recruit Count
41
Registration Number
NCT00561691
Locations
🇩🇪

University Bonn, Children's Medical Hospital, Bonn, Germany

Nimotuzumab in Children With HGG

Completed
Conditions
High Grade Glioma
First Posted Date
2007-11-21
Last Posted Date
2007-11-21
Lead Sponsor
Oncoscience AG
Target Recruit Count
45
Registration Number
NCT00561873
Locations
🇩🇪

University Bonn, Children's Medical Hospital, Bonn, Germany

Nimotuzumab in Adults With Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer, Advanced or Metastatic
Interventions
First Posted Date
2007-11-21
Last Posted Date
2015-10-15
Lead Sponsor
Oncoscience AG
Target Recruit Count
188
Registration Number
NCT00561990
Locations
🇩🇪

Marienhospital Herne, Herne, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.